Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-21-002361

Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schoeneck James A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-01-04 Exercise or conversion : show line 1 in the form +6,000 $9.78 $58,650 15,400 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-01-04 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −6,000 $9.78 2023-04-17 6,000 0 D
Loading xslF345X03/doc4.xml…